Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference

被引：13
|
作者：
Yanamandra, Uday [1 ]
Khattry, Navin [2 ]
Kumar, Shaji [3 ]
Raje, Noopur [4 ]
Jain, Arihant [1 ]
Jagannath, Sundar [5 ]
Menon, Hari [6 ]
Kumar, Lalit [7 ]
Varma, Neelam [1 ]
Varma, Subhash [1 ]
Saikia, Tapan [8 ]
Malhotra, Pankaj [1 ]
机构：
[1] PGIMER, Dept Internal Med, Chandigarh 160012, India
[2] Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India
[3] Mayo Clin, Rochester, MN USA
[4] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[5] Tisch Canc Inst, New York, NY USA
[6] Cytecare Hosp, Bengaluru, India
[7] AIIMS, Dept Med Oncol, New Delhi, India
[8] Prince Aly Khan Hosp, Bombay, Maharashtra, India
来源：
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION | 2017年 / 33卷 / 01期
关键词：
Multiple myeloma; Consensus; Indian scenario; Plasma cell dyscrasia; STEM-CELL TRANSPLANTATION; DIAGNOSIS; THERAPY;
D O I：
10.1007/s12288-016-0773-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent approval of the newer drugs widening the therapeutic armamentarium. Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians. There are challenges in management which are unique to the Indian patients. This review discusses these challenges and the consensus of the nation-wide experts in dealing with the same. We also briefly highlighted the perspective of international experts as discussed in the Myeloma State of the Art conference held in September 2016 at PGI, Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/recommendations that can be adapted to the Indian Scenario.
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [31] Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma
    Offidani, M.
    Boccadoro, M.
    Di Raimondo, F.
    Petrucci, M. T.
    Tosi, P.
    Cavo, M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (03) : 187 - 196
  • [32] Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art
    Martino, Massimo
    Paviglianiti, Annalisa
    Memoli, Mara
    Martinelli, Giovanni
    Cerchione, Claudio
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [33] Current State of Evidence on Definitions and Management of High-Risk Multiple Myeloma
    Lal, Bhavesh Mohan
    van Rhee, Frits
    Al Hadidi, Samer
    CURRENT ONCOLOGY REPORTS, 2025, : 258 - 277
  • [34] Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Bergsagel, P. Leif
    Shaughnessy, John
    Palumbo, Antonio
    Durie, Brian
    Fonseca, Rafael
    Stewart, A. Keith
    Harousseau, Jean-Luc
    Dimopoulos, Meletios
    Jagannath, Sundar
    Hajek, Roman
    Sezer, Orhan
    Kyle, Robert
    Sonneveld, Pieter
    Cavo, Michele
    Rajkumar, S. Vincent
    San Miguel, Jesus
    Crowley, John
    Avet-Loiseau, Herve
    BLOOD, 2011, 117 (18) : 4696 - 4700
  • [35] Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations
    Girmenia, Corrado
    Cavo, Michele
    Offidani, Massimo
    Scaglione, Francesco
    Corso, Alessandro
    Di Raimondo, Francesco
    Musto, Pellegrino
    Petrucci, Maria Teresa
    Barosi, Giovanni
    BLOOD REVIEWS, 2019, 34 : 84 - 94
  • [36] Second primary malignancies in multiple myeloma: an overview and IMWG consensus
    Musto, P.
    Anderson, K. C.
    Attal, M.
    Richardson, P. G.
    Badros, A.
    Hou, J.
    Comenzo, R.
    Du, J.
    Durie, B. G. M.
    San Miguel, J.
    Einsele, H.
    Chen, W. M.
    Garderet, L.
    Pietrantuono, G.
    Hillengass, J.
    Kyle, R. A.
    Moreau, P.
    Lahuerta, J. J.
    Landgren, O.
    Ludwig, H.
    Larocca, A.
    Mahindra, A.
    Cavo, M.
    Mazumder, A.
    McCarthy, P. L.
    Nouel, A.
    Rajkumar, S. V.
    Reiman, A.
    Serra, E. R.
    Sezer, O.
    Terpos, E.
    Turesson, I.
    Usmani, S.
    Weiss, B. M.
    Palumbo, A.
    ANNALS OF ONCOLOGY, 2017, 28 (02) : 228 - 245
  • [37] Evolving Paradigms of Therapy for Multiple Myeloma: State of the Art and Future Directions
    Goldsmith, Scott R.
    Vij, Ravi
    JCO ONCOLOGY PRACTICE, 2021, 17 (07) : 415 - +
  • [38] IMWG consensus on maintenance therapy in multiple myeloma
    Ludwig, Heinz
    Durie, Brian G. M.
    McCarthy, Philip
    Palumbo, Antonio
    San Miguel, Jesus
    Barlogie, Bart
    Morgan, Gareth
    Sonneveld, Pieter
    Spencer, Andrew
    Andersen, Kenneth C.
    Facon, Thierry
    Stewart, Keith A.
    Einsele, Hermann
    Mateos, Maria-Victoria
    Wijermans, Pierre
    Waage, Anders
    Beksac, Meral
    Richardson, Paul G.
    Hulin, Cyrille
    Niesvizky, Ruben
    Lokhorst, Henk
    Landgren, Ola
    Bergsagel, P. Leif
    Orlowski, Robert
    Hinke, Axel
    Cavo, Michele
    Attal, Michel
    BLOOD, 2012, 119 (13) : 3003 - 3015
  • [39] IMWG consensus on risk stratification in multiple myeloma
    Chng, W. J.
    Dispenzieri, A.
    Chim, C-S
    Fonseca, R.
    Goldschmidt, H.
    Lentzsch, S.
    Munshi, N.
    Palumbo, A.
    Miguel, J. S.
    Sonneveld, P.
    Cavo, M.
    Usmani, S.
    Durie, B. G. M.
    Avet-Loiseau, H.
    LEUKEMIA, 2014, 28 (02) : 269 - 277
  • [40] Diagnosis and management of multiple myeloma
    Smith, A
    Behrens, J
    Drayson, M
    Iggo, N
    Jackson, G
    Liddi, J
    Low, E
    Mehta, A
    Schey, S
    Singer, C
    Soutar, R
    Samson, D
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) : 522 - 540
12345